FDA: What's New, DrugsOct 9, 2026
Phase 1 Investigational New Drug (IND) Navigator
FDA's Phase 1 IND Navigator brings together resources for sponsors preparing investigational new drug applications for CDER and CBER. The page lists guidance, learning materials, procedures, manufacturing and controls resources, forms and a Phase 1 support team contact.
Why it matters: FDA's page groups application resources and support contacts relevant to preparing Phase 1 IND submissions.
Regulations and guidanceTrial conduct and operationsAI summary
Read at FDA